Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02196 FOSUN PHARMA
RT Nominal up18.940 +0.710 (+3.895%)
Latest  |  Final  |  Interim
Non-current Assets
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others22,680,9322.153%22,202,92720,846,45815,718,78913,012,075
Land & other Lease Assets5,073,3858.145%4,691,2714,248,0802,837,2292,569,796
Intangible Assets28,730,9412.100%28,139,95326,153,78724,288,67821,010,699
Interests in Asso. & JCEs26,333,2486.815%24,653,12423,881,02323,094,05522,626,827
Other Non-current Assets3,376,4144.086%3,243,8554,509,3105,895,2623,593,131

86,194,9203.936%82,931,13079,638,65871,834,01362,812,528
Current Assets
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Inventories6,252,472-13.862%7,258,6497,537,7686,882,4325,472,547
Trade Receivables9,426,89017.477%8,024,4337,668,2297,612,9426,045,947
Cash & Bank Balances13,104,229-3.103%13,523,93313,693,59116,241,31310,317,224
Other Current Assets5,037,081-10.198%5,609,0774,892,9814,122,9128,137,483
Assets Held for Sale0--74,9680419,578463,705

33,820,672-1.944%34,491,06033,792,56935,279,17730,436,906
Current Liabilities
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Trade Payables5,144,014-14.229%5,997,3856,159,6196,284,0415,063,693
S-T Debt & Leases21,440,722-6.779%22,999,77319,433,26717,214,87715,626,081
Other Current Liabilities9,839,58116.369%8,455,5118,164,6959,799,1528,628,699
Liab asso w/ Assets Held for Sale0--0000

36,424,317-2.746%37,452,66933,757,58133,298,07029,318,473
Net Current Assets(2,603,645)-12.087%(2,961,609)34,9881,981,1071,118,433
Total Assets Less Current Liabilities83,591,2754.529%79,969,52179,673,64673,815,12063,930,961
Non-current Liabilities
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
L-T Debt & Leases14,912,76114.842%12,985,46815,554,51212,844,8609,697,429
Other Non-current Liabilities6,876,540-2.993%7,088,7017,541,2496,912,0675,910,850

21,789,3018.544%20,074,16923,095,76119,756,92715,608,279
Capital and Reserves
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
  Share Capital2,670,429-0.034%2,671,3262,672,3992,672,1572,562,899
  Reserves46,032,7033.325%44,551,40442,973,98741,859,58436,575,773
  Others0--0000
Shareholders' Funds48,703,1323.135%47,222,73045,646,38644,531,74139,138,672
Non-controlling Interests13,098,8423.363%12,672,62210,931,4999,526,4529,184,010
Others0--0000

61,801,9743.183%59,895,35256,577,88554,058,19348,322,682
Commitments and Contingent Liabilities
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Commitments----3,331,1064,282,7986,469,8437,774,382
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 25/03/2026 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 3,370,562
%Change21.686%
EPS / (LPS)RMB 1.270
NBV Per Share (¥)RMB 18.451
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.